Glycogen storage disease type I (Von Glerke's disease) is an autosomal recessive disorder characterized by growth retardation hepatomegaly, recurrent episodes of hypoglycemia and acidosis. The enzyme deficiency in this disease has been shown to be glucose 6-phosphatase, which its activity has been reported mainly in liver and kidneys. In order to find a tissue that may exhibit glucose-6-phosphatase activity, full term human placentas were utilized. Placental slices were washed X3 with cold 0.15 M NaCl, then sonicated in 0.1M cacodylate buffer pH 6.5 and centrifuged for 10 min at 10,000 Xg. The supernatant fractions were assayed for glucose 6-phosphatase with glucose 6-phophate. The liberated glucose was determined by glucose oxidase. Normal human term placentas hydrolyze 33.0-80.0 ug glucose/mg/protein/h. D-1-14C-glucose-6-phosphate was used as an additional substrate and 14C-glucose was identified by thin layer chromatography. Extracts of normal term human placentas release 50%-86% of the label/mg protein/h. A pregnancy at risk for glycogen storage disease type I was followed and the full term placenta was assayed for glucose 6-phosphatase. The values obtained from the extracts of the placenta at risk released 16.5 ug glucose/mg protein/h. while a normal control placenta released 34.0 ug glucose/mg protein/h. This finding suggests heterozygous state of the newborn. These data offer a new source for the study of glucose-6-phosphatase and for possible prenatal detection.